Latest News and Press Releases

Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth

COPENHAGEN, Denmark, July 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that its partner, Eurofarma, has submitted a marketing authorization application to the Brazilian Health Regulatory...

KØBENHAVN, Danmark, 13. juli 2026 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabets partner, Eurofarma, har indsendt en ansøgning om markedsføringstilladelse til den brasilianske...

Intravacc Highlights Four Integrated Vaccine Development Platforms for CDMO Partners

AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans

Intravacc and SynphaBase Announce Strategic Partnership to Advance Conjugate Vaccine Development

Intravacc and SynphaBase Announce Strategic Partnership to Advance Conjugate Vaccine Development

Les deux entreprises uniront leurs compétences complémentaires en matière d’oligosaccharides synthétiques, de développement de procédés de conjugaison et de fabrication de vaccins selon les BPF afin...

Die Unternehmen werden ihr komplementäres Fachwissen in den Bereichen synthetische Oligosaccharide, Entwicklung von Konjugationsverfahren und GMP-konformer Impfstoffherstellung bündeln, um Partner bei...

Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention